Phase III, Double-blind, Randomized, Placebo-Controlled Multi-centre, study to assess the efficacy and safety of AZD9291 versus Placebo, in Patients with Epidermal Growth Factor Receptor Mutation Positive Stage IB-IIIA Non-small Cell Lung Resection With or Without Adjuvant Chemotherapy (ADAURA) Carcinoma, following Complete Tumour - Regional Cancer Care Associates LLC

Clinical Trials

Phase III, Double-blind, Randomized, Placebo-Controlled Multi-centre, study to assess the efficacy and safety of AZD9291 versus Placebo, in Patients with Epidermal Growth Factor Receptor Mutation Positive Stage IB-IIIA Non-small Cell Lung Resection With or Without Adjuvant Chemotherapy (ADAURA) Carcinoma, following Complete Tumour

Type of Cancer
Lung
Locations
Bethesda
Sponsor
Protocol Number
D5164C00001
Cancer Diagnosis
To Learn More Call
201-510-0910